Nationwide Fund Advisors increased its position in Halyard Health, Inc. (NYSE:HYH) by 0.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 116,821 shares of the medical instruments supplier’s stock after buying an additional 772 shares during the quarter. Nationwide Fund Advisors owned about 0.25% of Halyard Health worth $4,589,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. TIAA CREF Investment Management LLC raised its position in shares of Halyard Health by 35.2% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 202,901 shares of the medical instruments supplier’s stock worth $7,970,000 after buying an additional 52,881 shares during the period. Teachers Advisors LLC raised its position in shares of Halyard Health by 1.5% in the 2nd quarter. Teachers Advisors LLC now owns 84,542 shares of the medical instruments supplier’s stock worth $3,321,000 after buying an additional 1,223 shares during the period. Riverhead Capital Management LLC raised its position in shares of Halyard Health by 88.1% in the 2nd quarter. Riverhead Capital Management LLC now owns 3,197 shares of the medical instruments supplier’s stock worth $126,000 after buying an additional 1,497 shares during the period. AJO LP raised its position in shares of Halyard Health by 139.7% in the 2nd quarter. AJO LP now owns 79,246 shares of the medical instruments supplier’s stock worth $3,113,000 after buying an additional 46,181 shares during the period. Finally, Martingale Asset Management L P raised its position in shares of Halyard Health by 38.3% in the 2nd quarter. Martingale Asset Management L P now owns 98,639 shares of the medical instruments supplier’s stock worth $3,875,000 after buying an additional 27,304 shares during the period. 91.02% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Nationwide Fund Advisors Raises Position in Halyard Health, Inc. (HYH)” was first reported by Watch List News and is the property of of Watch List News. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.watchlistnews.com/nationwide-fund-advisors-raises-position-in-halyard-health-inc-hyh/1614543.html.

Several research analysts recently weighed in on the company. Zacks Investment Research lowered Halyard Health from a “buy” rating to a “sell” rating in a research report on Wednesday. Stifel Nicolaus reaffirmed a “buy” rating and issued a $45.00 target price on shares of Halyard Health in a research report on Thursday, September 21st. BidaskClub raised Halyard Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 19th. Deutsche Bank AG increased their target price on Halyard Health from $35.00 to $42.00 and gave the stock a “buy” rating in a research report on Thursday, August 3rd. Finally, Stephens raised Halyard Health from an “equal weight” rating to an “overweight” rating in a research report on Thursday, August 3rd. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the stock. Halyard Health has an average rating of “Buy” and an average price target of $42.25.

Halyard Health, Inc. (NYSE HYH) opened at 46.04 on Friday. The stock has a market capitalization of $2.15 billion, a price-to-earnings ratio of 44.27 and a beta of 1.75. Halyard Health, Inc. has a 12 month low of $31.59 and a 12 month high of $46.63. The company has a 50 day moving average price of $45.16 and a 200 day moving average price of $40.28.

Halyard Health (NYSE:HYH) last posted its quarterly earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 EPS for the quarter, beating the consensus estimate of $0.37 by $0.14. Halyard Health had a net margin of 3.06% and a return on equity of 8.29%. The business had revenue of $399.20 million for the quarter, compared to analysts’ expectations of $399.16 million. During the same period in the previous year, the company posted $0.45 EPS. Halyard Health’s revenue was down .2% on a year-over-year basis. Equities research analysts predict that Halyard Health, Inc. will post $1.96 earnings per share for the current year.

Halyard Health Company Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health, Inc. (NYSE:HYH).

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.